Enveric Biosciences, Inc. (NASDAQ: ENVB) reported Q1 EPS of ($1.22), $0.82 worse than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Enveric Biosciences, Inc. (ENVB) click here.